Table 2.
Variable | Adjusted odds ratio | 95% CI for adjusted odds ratio | P-value | ||
---|---|---|---|---|---|
| |||||
Lower limit | Upper limit | ||||
Age groups | 18–35 | R | - | - | |
36–50 | 1.355 | 1.034 | 1.775 | P = 0.028 | |
51–65 | 2.182 | 1.701 | 2.800 | P < 0.001 | |
>65 | 3.496 | 2.688 | 4.566 | P < 0.001 | |
Sex | Women | 1.016 | 0.912 | 1.132 | P = 0.769 |
Men | R | - | - | ||
Race | White | R | - | - | |
Black | 1.060 | 0.899 | 1.250 | P = 0.490 | |
Hispanic | 1.141 | 0.938 | 1.389 | P = 0.187 | |
Asian or Pacific Islander | 0.615 | 0.356 | 1.062 | P = 0.081 | |
Native American | 1.347 | 0.763 | 2.378 | P = 0.305 | |
Others | 1.796 | 1.331 | 2.411 | P < 0.001 | |
Sepsis | Yes | 3.383 | 3.025 | 3.784 | P < 0.001 |
No | R | - | - | ||
Liver disease | Yes | 2.369 | 1.996 | 2.816 | P < 0.001 |
No | R | - | - | ||
Metastatic cancer | Yes | 1.536 | 1.272 | 1.858 | P < 0.001 |
No | R | - | - | ||
Inflammatory bowel disease | Yes | 0.676 | 0.567 | 0.805 | P < 0.001 |
No | R | - | - | ||
Severe malnutrition | Yes | 1.642 | 1.414 | 1.908 | P < 0.001 |
No | R | - | - | ||
Chronic heart failure | Yes | 2.645 | 2.331 | 3.003 | P < 0.001 |
No | - | - | - | ||
Diabetes with chronic complications | Yes | 1.377 | 1.061 | 1.788 | P = 0.010 |
No | - | - | - | ||
Hospital: location/teaching status | Rural | 1.415 | 1.157 | 1.730 | P < 0.001 |
Urban nonteaching | 1.001 | 0.893 | 1.122 | P = 0.987 | |
Urban teaching | R | - | - | ||
Hospital: bed-size | Small | 0.807 | 0.669 | 0.972 | P = 0.024 |
Medium | 0.936 | 0.826 | 1.060 | P = 0.296 | |
Large | R | - | - | ||
Hospital: region | Northeast | 1.120 | 0.962 | 1.304 | P = 0.145 |
Midwest | 0.837 | 0.708 | 0.988 | P = 0.036 | |
South | 0.930 | 0.807 | 1.071 | P = 0.311 | |
West | R | - | - | ||
Primary expected payer | Medicare | R | - | - | |
Medicaid | 1.004 | 0.829 | 1.216 | P = 0.967 | |
Private insurance | 0.879 | 0.763 | 1.013 | P = 0.074 | |
Self-pay | 2.261 | 1.574 | 3.250 | P < 0.001 | |
Others | 1.734 | 1.237 | 2.432 | P < 0.001 |
reference category (adjusted for demographic factors and Elixhauser comorbidities).